Transplant International is looking for its publishing partner
ESOT is seeking a publisher for its flagship scientific journal, Transplant International, to discuss the transition to an open access journal.
ESOT is seeking a publisher for its flagship scientific journal, Transplant International, to discuss the transition to an open access journal.
This pre-print from TLJ 2.0 WS03 on ‘Managing Immunosuppressant Therapy in Potentially Cured Post-Kidney Transplant Cancer’ is now open for comments on Transplant Live. Led by Umberto Maggiore, this paper will be submitted to Transplant International once feedback from our community has been collated. Login & provide your input today
We are pleased to announce that our TLJ 2.0 report has been published and is available to read now. Providing a comprehensive summary of TLJ 2.0, this report covers all the highlights from the event, including the key discussion points and outcomes from some of the World’s leading transplant experts. Read the TLJ20Report for the